Commentary on Post, et al. Ultra-early tranexamic acid after subarachnoid hemorrhage: A randomized controlled trial. Lancet 2021

BACKGROUND: Tranexamic acid (TA) administration in aneurysmal subarachnoid hemorrhage (SAH) within the first 24 hours may reduce the incidence of early aneurysmal rebleeding. However, this is also the potential for an increased risk of delayed cerebral ischemia if TA is administered for more than 72...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Surg Neurol Int
Autori principali: Lo, Benjamin W. Y., Fukuda, Hitoshi, Tsang, Anderson C. O., Langer, David J., Miyawaki, Satoru, Koyanagi, Masaomi, Lui, Matthew Wai-Man
Natura: Artigo
Lingua:Inglês
Pubblicazione: Scientific Scholar 2021
Soggetti:
Commentary
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088487/
https://ncbi.nlm.nih.gov/pubmed/33948326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.25259/SNI_242_2021
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi